IMPDH inhibitors (c-a-i-r biosciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIMPDH inhibitors (c-a-i-r biosciences)
Drug Alias Nameinosine monophosphate dehydrogenase inhibitors (c-a-i-r biosciences)masked nucleotides (C-A-I-R Biosciences)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsRejection of renal transplantationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesC-A-I-R Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC-A-I-R Biosciences
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A